Edition:
United States

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

13.60USD
22 Jun 2018
Change (% chg)

$0.45 (+3.42%)
Prev Close
$13.15
Open
$13.25
Day's High
$13.70
Day's Low
$13.05
Volume
1,625,324
Avg. Vol
246,863
52-wk High
$19.80
52-wk Low
$4.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.314
FY 2017 Dec '17 0.00 -0.355
Sep '17 0.00 -0.350
Jun '17 0.00 -0.374
Mar '17 0.00 -0.332
FY 2016 Dec '16 0.00 -0.252
Sep '16 0.00 -1.154
Jun '16 0.00 -0.226
Mar '16 0.00 -0.142
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-19 6 0.00 0.00 0.00 10.00
Earnings (per share)
Quarter Ending Jun-18 6 -0.31 -0.29 -0.34 -0.32
Quarter Ending Sep-18 6 -0.32 -0.29 -0.35 -0.33
Year Ending Dec-18 6 -1.26 -1.17 -1.36 -1.38
Year Ending Dec-19 7 -1.38 -1.25 -1.52 -1.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 248.83 34.14
P/E High - Last 5 Yrs. -- 293.42 47.76
P/E Low - Last 5 Yrs. -- 100.49 25.04
Beta 5.12 0.74 0.78
Price to Sales (TTM) -- 246.52 8.17
Price to Book (MRQ) 4.17 23.99 4.30
Price to Tangible Book (MRQ) 4.17 30.50 6.00
Price to Cash Flow (TTM) -- 145.85 22.70
% Owned Institutions 88.74 11.95 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.70
Dividend Yield - 5 Year Avg -- 0.20 1.43
Dividend 5 Year Growth Rate -- 2.19 -6.26
Payout Ratio(TTM) -- 41.90 42.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 27.24 5.16
Sales (TTM) vs TTM 1 Yr. Ago -- 139.74 13.40
Sales - 5 Yr. Growth Rate -- 31.45 7.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.34 -84.38 39.68
EPS (TTM) vs TTM 1 Yr. Ago 29.09 -- --
EPS - 5 Yr. Growth Rate -- 49.40 8.05
Capital Spending - 5 Yr. Growth Rate -- 37.00 7.35

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.55
Current Ratio (MRQ) 20.61 6.39 3.63
LT Debt to Equity (MRQ) 0.00 22.27 13.12
Total Debt to Equity (MRQ) 0.00 26.58 17.55
Interest Coverage (TTM) -- -141.36 36.62

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.61 55.11
Gross Margin - 5 Yr. Avg. -- 55.12 52.97
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -170.99 15.68
Operating Margin (TTM) -- -889.67 -0.25
Operating Margin - 5 Yr. Avg. -- -184.49 10.87
Pre-Tax Margin (TTM) -- -784.00 1.68
Pre-Tax Margin - 5 Yr. Avg. -- -188.52 11.03
Net Profit Margin (TTM) -- -777.70 -1.61
Net Profit Margin - 5 Yr. Avg. -- -187.13 7.38
Effective Tax Rate (TTM) -- 15.50 29.97
Effective Tax Rate - 5 Yr. Avg. -- 19.39 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,135,587 727,159,976
Net Income/Employee (TTM) -1,553,889 -51,964 84,694,665
Receivable Turnover (TTM) -- 18.41 6.01
Inventory Turnover (TTM) -- 2.85 3.67
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -42.32 -3.55 10.32
Return on Assets - 5 Yr. Avg. -49.82 -0.74 10.99
Return on Investment (TTM) -44.25 -5.25 13.10
Return on Investment - 5 Yr. Avg. -52.45 2.09 14.28
Return on Equity (TTM) -44.25 -6.83 15.09
Return on Equity - 5 Yr. Avg. -66.91 -2.95 15.63
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 23.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Iovance Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -14.73 -15.77 31 80
13 Week -20.47 -25.28 40 35
26 Week 64.85 60.57 99 87
52 Week 102.99 79.38 99 86
YTD 70.00 64.98 99 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 93.16%
# of Holders: 181
Total Shares Held: 83,508,776
3 Mo. Net Change: 20,083,577
# New Positions: 47
# Closed Positions: 10
# Increased Positions: 117
# Reduced Positions: 40
# Net Buyers: 77
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.